Oral Presentation The Joint Annual Scientific Meetings of the Endocrine Society of Australia and the Society for Reproductive Biology 2017

‘Year in’ thyroid cancer (#6)

John Walsh 1 2
  1. Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
  2. School of Medicine and Pharmacology, University of Western Australia, Crawley, WA, Australia

The past year has seen significant advances in the epidemiology and management of thyroid cancer. This includes a better understanding of the increasing incidence of thyroid cancer worldwide, reclassification of a subtype of papillary thyroid cancer as non-invasive neoplasm, significant changes to TNM staging of thyroid cancer which take effect in 2018, and slow progress in understanding the genetic basis of familial nonmedullary thyroid cancer.